Financial Highlights
Transition of consolidated financial results of the past 5 years
* Fiscal years ended March 31.
1. Consolidated management performance
| FY ended Mar. 31, 2020 |
FY ended Mar. 31, 2021 |
FY ended Mar. 31, 2022 |
FY ended Mar. 31, 2023 |
FY ended Mar. 31, 2024 |
||
|---|---|---|---|---|---|---|
| Net sales (¥ Million) | 21,465 | 20,466 | 22,635 | 23,868 | 25,726 | |
| Particle Counter Division (¥ Million) | 4,558 | 5,172 | 6,265 | 6,619 | 7,559 | |
| Medical Instrument Division (¥ Million) | 12,232 | 11,081 | 11,707 | 12,175 | 12,749 | |
| Environmental Instrument Division (¥ Million) | 4,673 | 4,212 | 4,662 | 5,073 | 5,417 | |
| Operating income (¥ Million) | 2,485 | 2,220 | 3,104 | 2,844 | 3,474 | |
| Particle Counter Division (¥ Million) | 968 | 1,334 | 1,725 | 1,538 | 2,062 | |
| Medical Instrument Division (¥ Million) | 977 | 409 | 805 | 1,005 | 1,308 | |
| Environmental Instrument Division (¥ Million) | 538 | 476 | 573 | 299 | 104 | |
| Ordinary income (¥ Million) | 2,577 | 2,297 | 3,212 | 3,007 | 3,562 | |
| Net income (¥ Million) | 1,779 | 1,636 | 2,229 | 1,799 | 2,652 | |
| Net income per share (J¥) | 144.96 | 133.27 | 181.41 | 146.33 | 215.51 | |
| Return on equity (%) | 8.2 | 7.1 | 9.1 | 6.9 | 9.5 | |
| Return on assets (%) | 8.8 | 7.6 | 10.1 | 8.9 | 9.9 | |
| Operating margin (%) | 11.6 | 10.9 | 13.7 | 11.9 | 13.5 | |
2. Consolidated financial position
| FY ended Mar. 31, 2020 |
FY ended Mar. 31, 2021 |
FY ended Mar. 31, 2022 |
FY ended Mar. 31, 2023 |
FY ended Mar. 31, 2024 |
|
|---|---|---|---|---|---|
| Total assets (¥ Million) | 29,850 | 30,683 | 33,157 | 34,557 | 37,140 |
| Net assets (¥ Million) | 22,232 | 23,726 | 25,289 | 26,612 | 29,211 |
| Equity ratio (%) | 74.5 | 77.3 | 76.3 | 77.0 | 78.7 |
| Book-value per share (¥) | 1,810.87 | 1,931.15 | 2,057.40 | 2,163.30 | 2,372.88 |
3. Consolidated condition of cash flows
(¥ Million)
| FY ended Mar. 31, 2020 |
FY ended Mar. 31, 2021 |
FY ended Mar. 31, 2022 |
FY ended Mar. 31, 2023 |
FY ended Mar. 31, 2024 |
|
|---|---|---|---|---|---|
| Cash flows from operating activities | 2,696 | 2,064 | 2,841 | 1,783 | 2,857 |
| Cash flows from investing activities | ∆969 | ∆1,137 | ∆951 | ∆3,246 | ∆2,652 |
| Cash flows from financing activities | ∆528 | ∆566 | ∆541 | ∆577 | ∆565 |
| Cash and cash equivalents at end of year | 5,467 | 5,826 | 7,181 | 5,206 | 4,860 |